The Impact of COVID-19 is included in Typhoid Fever Vaccine Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Typhoid Fever Vaccine Trends and Forecast
The future of the global typhoid fever vaccine market looks promising with opportunities in the hospital & clinic and specialty center markets. The global typhoid fever vaccine market is expected to reach an estimated $1.0 billion by 2030 with a CAGR of 14.5% from 2024 to 2030. The major drivers for this market are rise in the prevalence of typhoid and growing demand for combined vaccines that offer protection against multiple diseases.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Typhoid Fever Vaccine by Segment
The study includes a forecast for the global typhoid fever vaccine by type, route of administration, end use, and region.
Typhoid Fever Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Live Attenuated Vaccine
• Capsular Polysaccharide Vaccine
• Conjugate Vaccine
• Others
Typhoid Fever Vaccine Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:
• Oral
• Injection
Typhoid Fever Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals & Clinics
• Specialty Centers
• Others
Typhoid Fever Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Typhoid Fever Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies typhoid fever vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the typhoid fever vaccine companies profiled in this report include-
• EMERGENT
• Bio Farma
• Bharat Biotech
• BIO-MED
• Pfizer
• GlaxoSmithKline
• Novartis
• Mylan
• Teva Pharmaceutical
• Sanofi
Typhoid Fever Vaccine Market Insights
Lucintel forecasts that capsular polysaccharide is expected to witness highest growth over the forecast period due to its efficiency at preventing infection from the bacteria, safe with limited side effects, and it can be administered orally or by injection, making them easy and convenient to use.
Within this market, hospital & clinic is expected to witness highest growth over the forecast period.
North America will remain the largest region due to increasing demand for vaccines across all age groups and high awareness for the typhoid vaccines in the region.
Features of the Global Typhoid Fever Vaccine Market
Market Size Estimates: Typhoid fever vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Typhoid fever vaccine market size by type, route of administration, end use, and region in terms of value ($B).
Regional Analysis: Typhoid fever vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, route of administration, end uses, and regions for the typhoid fever vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the typhoid fever vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the typhoid fever vaccine market size?
Answer: The global typhoid fever vaccine market is expected to reach an estimated $1.0 billion by 2030.
Q.2 What is the growth forecast for typhoid fever vaccine market?
Answer: The global typhoid fever vaccine market is expected to grow with a CAGR of 14.5% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the typhoid fever vaccine market?
Answer: The major drivers for this market are rise in the prevalence of typhoid and growing demand for combined vaccines that offer protection against multiple diseases.
Q4. What are the major segments for typhoid fever vaccine market?
Answer: The future of the typhoid fever vaccine market looks promising with opportunities in the hospital & clinic and specialty center markets.
Q5. Who are the key typhoid fever vaccine market companies?
Answer: Some of the key typhoid fever vaccine companies are as follows:
• EMERGENT
• Bio Farma
• Bharat Biotech
• BIO-MED
• Pfizer
• GlaxoSmithKline
• Novartis
• Mylan
• Teva Pharmaceutical
• Sanofi
Q6. Which typhoid fever vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that capsular polysaccharide is expected to witness highest growth over the forecast period due to its efficiency at preventing infection from the bacteria, safe with limited side effects, and it can be administered orally or by injection, making them easy and convenient to use.
Q7. In typhoid fever vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to increasing demand for vaccines across all age groups and high awareness for the typhoid vaccines in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the typhoid fever vaccine market by type (live attenuated vaccine, capsular polysaccharide vaccine, conjugate vaccine, and others), route of administration (oral and injection), end use (hospitals & clinics, specialty centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Typhoid Fever Vaccine Market, Typhoid Fever Vaccine Market Size, Typhoid Fever Vaccine Market Growth, Typhoid Fever Vaccine Market Analysis, Typhoid Fever Vaccine Market Report, Typhoid Fever Vaccine Market Share, Typhoid Fever Vaccine Market Trends, Typhoid Fever Vaccine Market Forecast, Typhoid Fever Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Typhoid Fever Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Typhoid Fever Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Typhoid Fever Vaccine Market by Type
3.3.1: Live Attenuated Vaccine
3.3.2: Capsular Polysaccharide Vaccine
3.3.3: Conjugate Vaccine
3.3.4: Others
3.4: Global Typhoid Fever Vaccine Market by Route of Administration
3.4.1: Oral
3.4.2: Injection
3.5: Global Typhoid Fever Vaccine Market by End Use
3.5.1: Hospitals & Clinics
3.5.2: Specialty Centers
3.5.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Typhoid Fever Vaccine Market by Region
4.2: North American Typhoid Fever Vaccine Market
4.2.2: North American Typhoid Fever Vaccine Market by End Use: Hospitals & Clinics, Specialty Centers, and Others
4.3: European Typhoid Fever Vaccine Market
4.3.1: European Typhoid Fever Vaccine Market by Type: Live Attenuated Vaccine, Capsular Polysaccharide Vaccine, Conjugate Vaccine, and Others
4.3.2: European Typhoid Fever Vaccine Market by End Use: Hospitals & Clinics, Specialty Centers, and Others
4.4: APAC Typhoid Fever Vaccine Market
4.4.1: APAC Typhoid Fever Vaccine Market by Type: Live Attenuated Vaccine, Capsular Polysaccharide Vaccine, Conjugate Vaccine, and Others
4.4.2: APAC Typhoid Fever Vaccine Market by End Use: Hospitals & Clinics, Specialty Centers, and Others
4.5: ROW Typhoid Fever Vaccine Market
4.5.1: ROW Typhoid Fever Vaccine Market by Type: Live Attenuated Vaccine, Capsular Polysaccharide Vaccine, Conjugate Vaccine, and Others
4.5.2: ROW Typhoid Fever Vaccine Market by End Use: Hospitals & Clinics, Specialty Centers, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Typhoid Fever Vaccine Market by Type
6.1.2: Growth Opportunities for the Global Typhoid Fever Vaccine Market by Route of Administration
6.1.3: Growth Opportunities for the Global Typhoid Fever Vaccine Market by End Use
6.1.4: Growth Opportunities for the Global Typhoid Fever Vaccine Market by Region
6.2: Emerging Trends in the Global Typhoid Fever Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Typhoid Fever Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Typhoid Fever Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: EMERGENT
7.2: Bio Farma
7.3: Bharat Biotech
7.4: BIO-MED
7.5: Pfizer
7.6: GlaxoSmithKline
7.7: Novartis
7.8: Mylan
7.9: Teva Pharmaceutical
7.10: Sanofi
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Typhoid Fever Vaccine Market Report.